The second edition of the formerly titled Just Say Know: A Counsellor’s Guide to Psychoactive Drugs, this indispensable counselling resource provides a practical understanding of psychoactive drug pharmacology and physiology. Rick Csiernik unpacks the risks and therapeutic applications of the most commonly used and misused drug families, including depressants, stimulants, hallucinogens, and psychotherapeutics. This new edition features a wide range of updated research and content addressing the recent rise of opioid, fentanyl, cannabis, novel psychoactive substances, and antipsychotic medication use, as well as the impacts of drug use on sleep and mental health. Two new appendixes are featured summarizing the effects of drugs on pregnancy and interactions drugs may have with certain brain chemicals. The Essential Guide to Psychoactive Drugs in Canada is the perfect addition to any addiction or mental health-related course. User-friendly and highly readable, this resource serves as a guide for service providers to deliver evidence-based care. This text is crucial for counsellors, therapists, instructors, and students looking to acquire an in-depth practical understanding of drug use, medication, and addiction in disciplines such as social work, sociology, pharmacology, health studies, nursing, psychology, and addiction studies.

Just Say Know is an essential resource for counsellors, educators, therapists, social workers, policy-makers, and professionals interested in acquiring a practical understanding of psychoactive drug pharmacology and physiology. In addition to evaluating traditional street narcotics, the most commonly abused drug families -- depressants, stimulants, hallucinogens, and psychotherapeutics -- are presented in an accessible format that unpacks risk and therapeutic applications. Csiernik demystifies the abuse of prescription compounds, as well as drugs that are new to North American communities. Pedagogical features include quizzes, case studies, figures, and a comprehensive list of addiction resource centres, making this book a perfect addition to any addictions-related program or course. Light on jargon and heavy on evidence, this manual supplies the blueprints that every service provider needs to dispense sound, evidence-based care.

Since 1975, Robert Julien's A Primer of Drug Action has been the definitive guide to the effects of psychoactive drugs on the brain and on behavior. Now fully updated, this popular guide continues to lead the way through a rapidly changing field, providing readers with a clear, contemporary, and objective look at every drug and medication that either positively or adversely affects brain function. This edition includes important new information on: -Herbal medications -Drug therapy for behavioral and anxiety disorders -Clinical practice guidelines for treating psychological disorders -Depression and the action of antidepressant drugs -The use of newer anticonvulsants in the treatment of bipolar disorder, pain syndromes, and behavioral disorders -Drug therapy for children, adolescents and the elderly -"New generation" antipsychotic agents Authoritative, comprehensive, and suitable for those with little background in biology, A Primer of Drug Action is an indispensable source of information for anyone interested in drug use, abuse, and education.

In the eight years since the publication of the second edition of this Guide, psycho phannacotherapy has made many advances not only through the discovery of new medications but by the effective directing of their use to an ever-increasing variety of clinical disorders. These welcome developments are reflected in the concurrent growth and development of the Guide itself, which now enters adulthood with renewed vigor. Under the thoughtful and scholarly leadership of Dr. Alan Gelenberg, the third edition has undergone a significant transformation designed to meet the needs of the modem clinician. The panel of contributors is nearly double that of the former edition with the addition of nine new authors, who have helped in the major revision and rewriting of the text and in a broadening of the topics included. As a conse quence, the reader is assured of a thorough and thoroughly up-to-date coverage of current psychopharmacology that is both accurate and aimed at clinical utility. Having reached maturity, the third edition, while maintaining the lineaments of its earlier versions, is a considerably expanded and strengthened guide to treatment. Although now more encyclopedic in content, the new Practitioner' s Guide to Psy choactive Drugs retains the virtues of a clinical vade mecum that informed its predecessors and have eamed it a place by the patient's bedside for weIl over a decade. One may confidently anticipate its long and flourishing career in the years ahead. John C. Nemiah, M.D.